Research Article
Biomarkers for Predicting Left Atrial or Left Atrial Appendage Thrombus in Anticoagulated Patients with Nonvalvular Atrial Fibrillation
Table 1
Baseline characteristics of NVAF patients with or without thrombus and SEC.
| Variable | No thrombus group (n = 84) | SEC group (n = 131) | Thrombus group (n = 45) | value |
| Age (years) | 62.58 ± 10.12 | 64.41 ± 8.42 | 63.56 ± 10.61 | 0.379 | Male | 51 (60.7) | 74 (56.5) | 27 (60) | 0.807 | Smoking history | 18 (21.4) | 36 (27.5) | 17 (37.8) | 0.139 | Drinking history | 13 (15.5) | 15 (11.5) | 10 (22.2) | 0.203 | History of coronary heart disease | 37 (44.0) | 47 (35.9) | 16 (35.6) | 0.441 | After PCI | 10 (11.9) | 14 (10.7) | 4 (8.9) | 0.870 | Old myocardial infarction | 3 (3.6) | 4 (3.1) | 1 (2.2) | 0.914 | Hypertension | 51 (60.7) | 77 (58.8) | 23 (51.1) | 0.559 | Diabetes mellitus | 16 (19.0) | 27 (20.6) | 10 (22.2) | 0.909 | Stroke/TIA | 11 (13.1) | 18 (13.7) | 19 (20) | 0.527 | Paroxysmal AF | 66 (78.6) | 65 (49.6) | 23 (46.7) | <0.001 | CHA2DS2-VASc score | 2.20 ± 1.63 | 2.19 ± 1.60 | 2.20 ± 1.71 | 0.630 | CHA2DS2-VASc score ≥2 | 53 (63.1) | 81 (61.8) | 26 (57.8) | 0.835 | Recurrent AF after ablation | 8 (9.5) | 11 (8.4) | 2 (4.4) | 0.590 |
|
|
AF = atrial fibrillation; TIA = transient ischemic attack; CHA 2DS 2-VASc = congestive heart failure, hypertension, age, diabetes mellitus, stroke, vascular disease, and sex. vs. no thrombus group. |